Latest Partner Fund Management, L.P. Stock Portfolio
Partner Fund Management, L.P. Performance:
2024 Q3: 3.42%YTD: 10.89%2023: 7.46%
Performance for 2024 Q3 is 3.42%, and YTD is 10.89%, and 2023 is 7.46%.
About Partner Fund Management, L.P. and 13F Hedge Fund Stock Holdings
PFM Health Sciences, LP is a hedge fund based in SAN FRANCISCO, CA. On 06-Sep-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $3.3 Billions. In it's latest 13F Holdings report, PFM Health Sciences, LP reported an equity portfolio of $1.8 Billions as of 30 Sep, 2024.
The top stock holdings of PFM Health Sciences, LP are LLY, THC, CYTK. The fund has invested 15% of it's portfolio in ELI LILLY & CO and 5.6% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off CENTENE CORP DEL (CNC), DEXCOM INC (DXCM) and JOHNSON & JOHNSON (JNJ) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), IMMUNOVANT INC (IMVT) and BOSTON SCIENTIFIC CORP (BSX). PFM Health Sciences, LP opened new stock positions in INSPIRE MED SYS INC (INSP), ASCENDIS PHARMA A/S and SPDR SER TR (BIL). The fund showed a lot of confidence in some stocks as they added substantially to KEROS THERAPEUTICS INC (KROS), WATERS CORP (WAT) and BOUNDLESS BIO INC.
The top stock holdings of PFM Health Sciences, LP are LLY, THC, CYTK. The fund has invested 15% of it's portfolio in ELI LILLY & CO and 5.6% of portfolio in TENET HEALTHCARE CORP.
The fund managers got completely rid off CENTENE CORP DEL (CNC), DEXCOM INC (DXCM) and JOHNSON & JOHNSON (JNJ) stocks. They significantly reduced their stock positions in ARCELLX INC (ACLX), IMMUNOVANT INC (IMVT) and BOSTON SCIENTIFIC CORP (BSX). PFM Health Sciences, LP opened new stock positions in INSPIRE MED SYS INC (INSP), ASCENDIS PHARMA A/S and SPDR SER TR (BIL). The fund showed a lot of confidence in some stocks as they added substantially to KEROS THERAPEUTICS INC (KROS), WATERS CORP (WAT) and BOUNDLESS BIO INC.
Partner Fund Management, L.P. Annual Return Estimates Vs S&P 500
Our best estimate is that PFM Health Sciences, LP made a return of 3.42% in the last quarter. In trailing 12 months, it's portfolio return was 25.05%.
New Buys
| Ticker | $ Bought |
|---|---|
| inspire med sys inc | 20,750,900 |
| ascendis pharma a/s | 13,552,300 |
| spdr ser tr | 12,038,300 |
| concentra group holdings par | 6,708,000 |
| tg therapeutics inc | 5,459,460 |
| veeva sys inc | 4,041,890 |
| longboard pharmaceuticals in | 3,789,990 |
| ocular therapeutix inc | 3,504,730 |
New stocks bought by Partner Fund Management, L.P.
Additions
| Ticker | % Inc. |
|---|---|
| keros therapeutics inc | 202 |
| waters corp | 148 |
| boundless bio inc | 71.17 |
| acadia healthcare company in | 63.31 |
| pmv pharmaceuticals inc | 57.67 |
| ascendis pharma a/s | 27.78 |
| xenon pharmaceuticals inc | 19.48 |
| amgen inc | 11.43 |
Additions to existing portfolio by Partner Fund Management, L.P.
Reductions
| Ticker | % Reduced |
|---|---|
| arcellx inc | -80.58 |
| immunovant inc | -74.03 |
| boston scientific corp | -68.84 |
| praxis precision medicines i | -59.6 |
| compass pathways plc | -58.58 |
| centessa pharmaceuticals plc | -57.66 |
| uniqure nv | -55.7 |
| intra-cellular therapies inc | -54.59 |
Partner Fund Management, L.P. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| biomarin pharmaceutical inc | -14,914,500 |
| outset med inc | -2,866,710 |
| centene corp del | -39,681,400 |
| eyepoint pharmaceuticals inc | -2,548,460 |
| dexcom inc | -26,191,600 |
| tenaya therapeutics inc | -688,888 |
| johnson & johnson | -18,829,100 |
| sana biotechnology inc | -605,154 |
Partner Fund Management, L.P. got rid off the above stocks
Sector Distribution
PFM Health Sciences, LP has about 92.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 92.8 |
| Others | 7.2 |
Market Cap. Distribution
PFM Health Sciences, LP has about 68.7% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 40.2 |
| MEGA-CAP | 28.5 |
| MID-CAP | 16.7 |
| UNALLOCATED | 7.2 |
| SMALL-CAP | 4.8 |
| MICRO-CAP | 2.6 |
Stocks belong to which Index?
About 76.8% of the stocks held by PFM Health Sciences, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 61.4 |
| Others | 23.2 |
| RUSSELL 2000 | 15.4 |
Partner Fund Management, L.P. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Partner Fund Management, L.P.
PFM Health Sciences, LP has 72 stocks in it's portfolio. About 49.9% of the portfolio is in top 10 stocks. EW proved to be the most loss making stock for the portfolio. THC was the most profitable stock for PFM Health Sciences, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 4.52 | 403,861 | 79,754,500 | unchanged | 0.00 | ||
| ACHC | acadia healthcare company in | 2.46 | 686,150 | 43,508,800 | added | 63.31 | ||
| ACLX | arcellx inc | 0.29 | 60,602 | 5,060,870 | reduced | -80.58 | ||
| ADAP | adaptimmune therapeutics plc | 0.54 | 10,000,800 | 9,504,750 | reduced | -4.94 | ||
| ALKS | alkermes plc | 0.32 | 205,073 | 5,739,990 | unchanged | 0.00 | ||
| AMGN | amgen inc | 1.65 | 90,297 | 29,094,600 | added | 11.43 | ||
| APLS | apellis pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARKF | ark etf tr | 0.13 | 86,934 | 2,225,510 | new | |||
| AXSM | axsome therapeutics inc | 2.38 | 467,427 | 42,007,700 | unchanged | 0.00 | ||
| BDX | becton dickinson & co | 1.39 | 101,680 | 24,515,000 | reduced | -22.61 | ||
| BIL | spdr ser tr | 0.68 | 121,845 | 12,038,300 | new | |||
| BMRN | biomarin pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corp | 0.52 | 108,469 | 9,089,700 | reduced | -68.84 | ||
| CAPR | capricor therapeutics inc | 0.13 | 152,779 | 2,323,770 | new | |||
| CELC | celcuity inc | 0.60 | 710,255 | 10,589,900 | reduced | -15.14 | ||
| CGEM | cullinan therapeutics inc | 0.17 | 182,810 | 3,060,240 | reduced | -38.25 | ||
| CLDX | celldex therapeutics inc new | 0.10 | 52,120 | 1,771,560 | unchanged | 0.00 | ||
| CMPS | compass pathways plc | 0.16 | 451,267 | 2,842,980 | reduced | -58.58 | ||
| CNC | centene corp del | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTA | centessa pharmaceuticals plc | 0.24 | 269,158 | 4,303,840 | reduced | -57.66 | ||